sur B.R.A.I.N. Biotechnology Research And Information Network AG (ETR:DE000520)
BRAIN Biotech Expands European Operations and Acquires Full Ownership of Breatec B.V.
BRAIN Biotech AG has completed the buyout of minority shares in its Dutch subsidiary, Breatec B.V. This acquisition makes Breatec B.V. fully owned by BRAIN Biotech AG. To accommodate growing demands in the flour and bakery enzymes sector, BRAIN Biotech announced a new production site near Eindhoven, Netherlands. This location will serve as an integrated production and warehousing hub, featuring an expanded Baking Application Center focusing on enzyme-based applications.
The company plans to close its Büttelborn, Germany site, transferring operations to the new Dutch facility. This move is expected to generate synergies by consolidating production. As part of this transition, BRAIN Biotech aims to enhance customer service through a centralized European hub. Although some staff reductions are expected in Büttelborn, the changes aim to optimize production and strengthen customer interactions.
R. H.
Copyright © 2025 FinanzWire, tous droits de reproduction et de représentation réservés.
Clause de non responsabilité : bien que puisées aux meilleures sources, les informations et analyses diffusées par FinanzWire sont fournies à titre indicatif et ne constituent en aucune manière une incitation à prendre position sur les marchés financiers.
Cliquez ici pour consulter le communiqué de presse ayant servi de base à la rédaction de cette brève
Voir toutes les actualités de B.R.A.I.N. Biotechnology Research And Information Network AG